Post written by: BioTech Health X
You May Also Like
Istari Oncology Begins Phase 1 / Phase 2 Sub-Study To Evaluate PVSRIPO in Head and Neck Cancer Patients
- BioTech Health X
- August 17, 2021
- 3 minute read
Istari Oncology, Inc., a clinical-stage biotechnology firm focused on unique immunotherapy systems for the treatment of strong lumps,…
Moderna Announces Ministry of Food and Drug Safety of South Korea (MFDS) COVID-19 Authorization
- BioTech Health X
- May 21, 2021
- 2 minute read
Moderna, Inc., (NASDAQ: MRNA) has recently been authorized by the Ministry of Food and Drug Safety of South…
ImmunityBio Announces FDA Acceptance of BLA for N-803 Anktiva Bladder Cancer Drug
- BioTech Health X
- July 28, 2022
- 3 minute read
In breaking news, clinical-stage biotechnology company ImmunityBio, Inc. (NASDAQ: IBRX) has announced acceptance by the FDA review of…
Infinity Pharmaceuticals Add 2 New Members to Board of Directors
- BioTech Health X
- September 7, 2021
- 3 minute read
Table of Contents Hide About Infinity PharmaceuticalsAbout Dr. Robert Ilaria – Infinity Pharmaceuticals Chief Medical OfficerAbout Dr. Brian…
Inhibikase Therapeutics To Present Phase 1/1b Trial Results at AD/PD Alzheimer’s & Parkinson’s Diseases Conference
- BioTech Health X
- March 8, 2022
- 3 minute read
Table of Contents Hide About Inhibikase TherapeuticsAbout Parkinson’s DiseaseIkT-148009 for Parkinson’s DiseaseInhibikase’s AD/PD, Alzheimer’s & Parkinson’s Diseases Conference…
Taysha Gene (TSHA) Reports Strong Q2 2024 Results and Advances TSHA-102 Trials
- BioTech Health X
- November 5, 2024
- 2 minute read
Table of Contents Hide Positive Clinical Data from TSHA-102 TrialsStrong Financial Position Enhances Growth PotentialUpcoming Milestones and Market…